COVID-19 still presents a threat to America and the rest of the world, even with the COVID vaccines now being distributed including Pfizer and Moderna. As we head into the fall months of 2021, the Delta Variant of COVID-19 is on the rise and Global WholeHealth Partners continues to do its part in the fight by sourcing and supplying in demand COVID-19 diagnostic testing kits and PPE supplies.
We all can do our part to help slow the spread of COVID-19 by social distancing where we can, staying quarantined when we are sick, and using PPE supplies when leaving the house. Even when masks are not required anymore in some places, such as shopping malls, grocery stores and restaurants, it doesn’t hurt to continue to use PPE supplies where we can. Oftentimes, negative COVID-19 tests are required for travel, even when vaccinated.
Get in touch with our customer service agents today for bulk purchases of COVID-19 diagnostic testing kits and PPE supplies. Visit us online to view our COVID-19 medical supply page and call 877-568-4947 to place your order.
About Global WholeHealth Partners OTC (GWHP)
GWHP provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines that detect between 1 - 1 ½ hours and Rapid Diagnostic Testing (RDT) Serum Plasma that detect between 15 -20 minutes, which predict diseases ahead of its industry competitors. Our focus is encompassing, improving, and preserving the quality of life by providing fast, adequate and accurate test results to prompt early treatment and cut cost of accumulated diseases all over the world. By so doing, GWHP has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. MISSION GWHP is committed to building long term shareholder value through the vertical integration of proven, well established business that effectively and efficiently control disease outbreak and significantly reducing health care costs. VISION Our vision is to lead the industry in infectious disease diagnostics and provide molecular solutions that lessen the time to diagnose medical results, empower healthcare professionals to make better diagnostic decisions, and lower healthcare costs.